{"nct_id":"NCT02294227","title":"16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2015-05-29","start_date_type":"ACTUAL","primary_completion_date":"2016-02-16","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}